logo
Select company
Select metric
$ -0.3EBITDA per Share
VS
Market
27
Sector
65
Industry
82
History
94
$ 4.72Close
$ 1.13 - $ 5.34 52-Week Range
Ticker Information

Ticker

TSHA

Company Name

TAYSHA GENE THERAPIES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TAYSHA GENE THERAPIES INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TSHA - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -90.23M$ -0.31297.99M
3/31/2025$ -84.24M$ -0.311269.31M
12/31/2024$ -86.73M$ -0.351250.13M
9/30/2024$ -19.48M$ -0.071267.82M
6/30/2024$ -109.55M$ -0.471232.82M
3/31/2024$ -111.78M$ -0.481231.25M
12/31/2023$ -104.02M$ -0.91116.12M
9/30/2023$ -206.36M$ -1.641125.7M
6/30/2023$ -116.17M$ -1.81164.24M
3/31/2023$ -126.34M$ -2163.26M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TAYSHA GENE THERAPIES INC's latest trailing twelve months (TTM) EBITDAPS stands at $ 0.
  • Over the past 5 years, TAYSHA GENE THERAPIES INC's average EBITDAPS has been $ -2.21.
  • The median EBITDAPS for TAYSHA GENE THERAPIES INC during this period was $ -1.9
  • TAYSHA GENE THERAPIES INC reached its highest EBITDAPS over the past 5 years at $ -0.07.
  • The lowest EBITDAPS recorded by TAYSHA GENE THERAPIES INC in the same timeframe $ -4.97

TAYSHA GENE THERAPIES INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
RLAY : RELAY THERAPEUTICS INC $ -1.79PRAX : PRAXIS PRECISION MEDICINES INC $ -11.63LENZ : LENZ THERAPEUTICS INC $ -1.85DNTH : DIANTHUS THERAPEUTICS INC $ -3.19IMNM : IMMUNOME INC $ -2.41TNXP : TONIX PHARMACEUTICALS HOLDING CORP $ -10.84PRME : PRIME MEDICINE INC $ -1.42NUVB : NUVATION BIO INC $ -0.59PGEN : PRECIGEN INC $ -0.41ATAI : ATAI LIFE SCIENCES NV $ -0.59

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for TAYSHA GENE THERAPIES INC is calculated as follows: EBITDA [ $ 0 ] / (Shares WA [ 11.73M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 0 ]

TSHA - EBITDA per Share, Last 5 years

$ -4.97

Minimum

Mar 31, 2022

$ -0.07

Maximum

Sep 30, 2024

$ -2.21

Average

$ -1.9

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26